Michael Glynn has been appointed to chief commercial officer at Pacific Biosciences. He joins PacBio from Genzyme, where he served as the regional president of Japan and Asia Pacific, and also as a senior vice president.
Previously, he spent seven years at Boston Scientific, most recently as president of its Endovations division in the US. He also held various roles at Memtec, Baxter International, Burroughs Wellcome, Estee Lauder, and Elizabeth Arden.
He holds an MBA from Macquarie University in Sydney and a BS from the National University of Ireland.